Filter posts

Jim Greenwood Talks 21st Century Cures with Chairman Fred Upton

Recently, BIO CEO and President Jim Greenwood sat down with House Energy and Commerce Chairman …

The Cancer Death-Panel App

In an article for the New York Post, Robert Goldberg, vice president of the Center …

Grass Stains, Flip Flops, Water Fights… and Biotech!

July is notorious for the beaming rays and hot summer weather. Luckily our atmosphere protects …

AIR 340B New Report: Contract Pharmacy Growth in 340B

Today, the Alliance for Integrity and Reform of 340B (AIR 340B) released a white paper …

The Value of Prevention

Vaccines are widely recognized as one of the most important advances in medical history. Once-devastating …

New CDC Tool to Track Antibiotic Use & Resistance

Antibiotic resistance is quickly becoming one of the most serious threats facing our health care …

Is Regulatory Transformation for Alzheimer’s Therapies Needed?

BIO 2014’s  session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move …

Access to Big Data

Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James …

Industry-Disease Foundation Partnerships Thrive on Communication & Transparency

Disease foundations are playing an increasingly important role in advancing research and helping to bring …

Seeing is Believing

PET and MRI imaging helps companies to make go/no go decisions earlier Attrition or failure …